These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 31020692)
1. The promising novel biomarkers and candidate small molecule drugs in lower-grade glioma: Evidence from bioinformatics analysis of high-throughput data. Zhang B; Wu Q; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Wang Z; Zhou YL J Cell Biochem; 2019 Sep; 120(9):15106-15118. PubMed ID: 31020692 [TBL] [Abstract][Full Text] [Related]
2. Identification of Hub Gene GRIN1 Correlated with Histological Grade and Prognosis of Glioma by Weighted Gene Coexpression Network Analysis. Yang A; Wang X; Hu Y; Shang C; Hong Y Biomed Res Int; 2021; 2021():4542995. PubMed ID: 34840971 [TBL] [Abstract][Full Text] [Related]
3. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer. Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489 [TBL] [Abstract][Full Text] [Related]
4. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma. Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355 [TBL] [Abstract][Full Text] [Related]
5. Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis. Qi C; Lei L; Hu J; Wang G; Liu J; Ou S J Mol Neurosci; 2020 Oct; 70(10):1521-1532. PubMed ID: 32642801 [TBL] [Abstract][Full Text] [Related]
6. The promising novel biomarkers and candidate small molecule drugs in kidney renal clear cell carcinoma: Evidence from bioinformatics analysis of high-throughput data. Zhang B; Wu Q; Wang Z; Xu R; Hu X; Sun Y; Wang Q; Ju F; Ren S; Zhang C; Qin L; Ma Q; Zhou YL Mol Genet Genomic Med; 2019 May; 7(5):e607. PubMed ID: 30793530 [TBL] [Abstract][Full Text] [Related]
7. Identification of Hub Genes of Mesio Temporal Lobe Epilepsy and Prognostic Biomarkers of Brain Low-grade Gliomas Based on Bioinformatics Analysis. Xu J; Sun M; Wang Y; Xie A; Gao J Cell Transplant; 2020; 29():963689720978722. PubMed ID: 33327771 [TBL] [Abstract][Full Text] [Related]
8. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data. Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666 [TBL] [Abstract][Full Text] [Related]
9. Use of Genome-Scale Integrated Analysis to Identify Key Genes and Potential Molecular Mechanisms in Recurrence of Lower-Grade Brain Glioma. Deng T; Gong YZ; Wang XK; Liao XW; Huang KT; Zhu GZ; Chen HN; Guo FZ; Mo LG; Li LQ Med Sci Monit; 2019 May; 25():3716-3727. PubMed ID: 31104065 [TBL] [Abstract][Full Text] [Related]
10. Validation of the functions and prognostic values of synapse-associated proteins in lower-grade glioma. Lin H; Yang Y; Hou C; Huang Y; Zhou L; Zheng J; Lv G; Mao R; Chen S; Xu P; Zhou Y; Wang P; Zhou D Biosci Rep; 2021 May; 41(5):. PubMed ID: 33969375 [TBL] [Abstract][Full Text] [Related]
11. Identification of novel biomarkers and small molecule drugs in human colorectal cancer by microarray and bioinformatics analysis. Chen J; Wang Z; Shen X; Cui X; Guo Y Mol Genet Genomic Med; 2019 Jul; 7(7):e00713. PubMed ID: 31087508 [TBL] [Abstract][Full Text] [Related]
12. Identification of Core Biomarkers Associated with Outcome in Glioma: Evidence from Bioinformatics Analysis. Geng RX; Li N; Xu Y; Liu JH; Yuan FE; Sun Q; Liu BH; Chen QX Dis Markers; 2018; 2018():3215958. PubMed ID: 30405856 [TBL] [Abstract][Full Text] [Related]
13. Identification of potential biomarkers related to glioma survival by gene expression profile analysis. Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197 [TBL] [Abstract][Full Text] [Related]
14. Computational screening of potential glioma-related genes and drugs based on analysis of GEO dataset and text mining. Jiang Z; Shi Y; Tan G; Wang Z PLoS One; 2021; 16(2):e0247612. PubMed ID: 33635875 [TBL] [Abstract][Full Text] [Related]
15. Bioinformatics analysis of C3 in brain low-grade gliomas as potential therapeutic target and promoting immune cell infiltration. Wu S; Miao K; Wang L; Ma Y; Wu X Med Oncol; 2022 Jan; 39(2):27. PubMed ID: 35018510 [TBL] [Abstract][Full Text] [Related]
16. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry. Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924 [TBL] [Abstract][Full Text] [Related]
17. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis. Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282 [TBL] [Abstract][Full Text] [Related]
18. Identification of genes related to low-grade glioma progression and prognosis based on integrated transcriptome analysis. Jiang Y; He J; Guo Y; Tao H; Pu F; Li Y J Cell Biochem; 2020 Jun; 121(5-6):3099-3111. PubMed ID: 31886582 [TBL] [Abstract][Full Text] [Related]
19. Adaptor Protein Complex 1 Sigma 3 Is Highly Expressed in Glioma and Could Enhance Its Progression. Ye T; Cheng Y; Li C Comput Math Methods Med; 2021; 2021():5086236. PubMed ID: 34367317 [TBL] [Abstract][Full Text] [Related]
20. Bioinformatics analysis of high-throughput data to validate potential novel biomarkers and small molecule drugs for glioblastoma multiforme. Qi F; Li Q; Lu X; Chen Z J Int Med Res; 2020 Jul; 48(7):300060520924541. PubMed ID: 32634050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]